US20090169491A1 - Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses - Google Patents

Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses Download PDF

Info

Publication number
US20090169491A1
US20090169491A1 US12/224,788 US22478807A US2009169491A1 US 20090169491 A1 US20090169491 A1 US 20090169491A1 US 22478807 A US22478807 A US 22478807A US 2009169491 A1 US2009169491 A1 US 2009169491A1
Authority
US
United States
Prior art keywords
igf
peptide
seq
peptides
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/224,788
Other languages
English (en)
Inventor
Yong Ji Chung
Young Deug Kim
Eun Mi Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caregen Co Ltd
Original Assignee
Caregen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caregen Co Ltd filed Critical Caregen Co Ltd
Assigned to CAREGEN CO., LTD reassignment CAREGEN CO., LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHUNG, YONG JI, KIM, EUN MI, KIM, YOUNG DEUG
Publication of US20090169491A1 publication Critical patent/US20090169491A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
US12/224,788 2006-03-06 2007-03-06 Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses Abandoned US20090169491A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20060021099 2006-03-06
KR10-2006-0021099 2006-03-06
PCT/KR2007/001086 WO2007102686A1 (en) 2006-03-06 2007-03-06 Peptides having activities of insulin like growth factor-1 and their uses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2007/001086 A-371-Of-International WO2007102686A1 (en) 2006-03-06 2007-03-06 Peptides having activities of insulin like growth factor-1 and their uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/659,546 Division US8263095B2 (en) 2006-03-06 2010-03-12 Methods of use for peptides having activities of insulin like growth factor-1

Publications (1)

Publication Number Publication Date
US20090169491A1 true US20090169491A1 (en) 2009-07-02

Family

ID=38475090

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/224,788 Abandoned US20090169491A1 (en) 2006-03-06 2007-03-06 Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses
US12/659,546 Active US8263095B2 (en) 2006-03-06 2010-03-12 Methods of use for peptides having activities of insulin like growth factor-1

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/659,546 Active US8263095B2 (en) 2006-03-06 2010-03-12 Methods of use for peptides having activities of insulin like growth factor-1

Country Status (6)

Country Link
US (2) US20090169491A1 (ko)
EP (2) EP2270039B1 (ko)
JP (1) JP4971373B2 (ko)
KR (1) KR100861914B1 (ko)
CN (1) CN101395179B (ko)
WO (1) WO2007102686A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10351597B2 (en) 2015-04-28 2019-07-16 Caregen Co., Ltd. Peptide with anti-obesity and anti-diabetes activity and use thereof

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2489506A1 (en) 2002-06-19 2003-12-31 Palomar Medical Technologies, Inc. Method and apparatus for treatment of cutaneous and subcutaneous conditions
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
KR101163171B1 (ko) * 2009-01-20 2012-07-19 (주)케어젠 노긴?유래 펩타이드 및 그의 용도
KR101417872B1 (ko) 2009-07-22 2014-07-09 입센 파마 에스.에이.에스 59번 위치에 아미노산 치환을 포함하는 인슐린 유사 성장 인자-1(ｉｇｆ-1)의 유사체
US20130035675A1 (en) * 2011-08-04 2013-02-07 Cynosure, Inc. Non-uniform beam phototherapeutic dosage determination method
WO2013158299A1 (en) 2012-04-18 2013-10-24 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US9700504B2 (en) 2012-06-19 2017-07-11 Debraj Shome Composition and method for an intradermal hair growth solution
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
JP5559406B2 (ja) * 2013-09-11 2014-07-23 株式会社 資生堂 シミを有する蓋然性を評価する方法
BR102013025813A2 (pt) * 2013-10-04 2015-08-25 Sanofi Aventis Farmacêutica Ltda Composição para tratamento de úlceras diabéticas, processo de preparação da composição e seu uso
KR102079050B1 (ko) * 2017-12-18 2020-02-19 주식회사 엘지생활건강 인슐린유사 성장인자-1의 융합 단백질을 포함하는 피부개선용 화장료 조성물
KR102627248B1 (ko) 2018-02-26 2024-01-19 싸이노슈어, 엘엘씨 Q-스위치드 캐비티 덤핑 서브 나노초 레이저
CN110642937B (zh) * 2019-10-11 2021-04-06 南开大学 多肽衍生物、纳米纤维及其应用
KR20210075897A (ko) * 2019-12-13 2021-06-23 (주)넥스젠바이오 텐덤 인슐린 유사 성장인자-1 및 이를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물
CN111568781A (zh) * 2020-06-23 2020-08-25 上海美月生物科技有限公司 一种护肤凝胶及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420112A (en) * 1992-06-12 1995-05-30 Lewis; Michael E. Prevention and treatment of peripheral neuropathy
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5679640A (en) * 1991-02-12 1997-10-21 Cytel Corporation Immunosuppressant peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6450899A (en) * 1987-08-21 1989-02-27 Sumitomo Pharma Novel insulin-like growth factor-i derivative and production thereof
US6310040B1 (en) * 1991-11-08 2001-10-30 Cephalon, Inc. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
EP0639981A4 (en) 1992-05-08 1995-06-28 Univ Jefferson ANALOGS OF THE IGF FACTOR (01/18/94).
NZ255461A (en) * 1992-08-20 1996-12-20 Biotechnology & Biolog Science Specific binding molecules for insulin-like-growth-factor-1 (igf-1), antigens capable of generating them and their use in enhancing igf-1 activity
US6034062A (en) * 1997-03-13 2000-03-07 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-9 compositions and their uses
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
US20020081324A1 (en) * 2002-01-22 2002-06-27 Twine Rebecca Wright Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood
KR20040076780A (ko) * 2003-02-26 2004-09-03 (주)케어젠 재조합 인슐린 유사 성장인자를 함유하는 화장료 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5679640A (en) * 1991-02-12 1997-10-21 Cytel Corporation Immunosuppressant peptides
US5420112A (en) * 1992-06-12 1995-05-30 Lewis; Michael E. Prevention and treatment of peripheral neuropathy
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10351597B2 (en) 2015-04-28 2019-07-16 Caregen Co., Ltd. Peptide with anti-obesity and anti-diabetes activity and use thereof
US10626145B2 (en) 2015-04-28 2020-04-21 Caregen Co., Ltd. Peptide with anti-obesity and anti-diabetes activity and use thereof
US10738081B2 (en) 2015-04-28 2020-08-11 Caregen Co., Ltd. Peptide with anti-obesity and anti-diabetes activity and use thereof
US11186611B2 (en) 2015-04-28 2021-11-30 Caregen Co., Ltd. Peptide with anti-obesity and anti-diabetes activity and use thereof

Also Published As

Publication number Publication date
EP1989226A1 (en) 2008-11-12
EP1989226A4 (en) 2009-11-18
WO2007102686A8 (en) 2010-03-04
EP2270039B1 (en) 2013-05-29
CN101395179A (zh) 2009-03-25
KR100861914B1 (ko) 2008-10-09
CN101395179B (zh) 2013-01-02
WO2007102686A1 (en) 2007-09-13
KR20070091568A (ko) 2007-09-11
US8263095B2 (en) 2012-09-11
EP2270039A1 (en) 2011-01-05
JP2009529036A (ja) 2009-08-13
US20100278756A1 (en) 2010-11-04
JP4971373B2 (ja) 2012-07-11

Similar Documents

Publication Publication Date Title
US8263095B2 (en) Methods of use for peptides having activities of insulin like growth factor-1
EP2078035B1 (en) Peptides having activities of epidermal growth factor and its uses
US8106017B2 (en) Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same
EP2142572B1 (en) Tgfp-cap peptide and its uses
EP2275440B1 (en) Growth factor-mimicking peptides and uses thereof
US7939495B2 (en) Method for improving skin conditions
US9303064B2 (en) Peptide inhibiting matrix metalloproteanases activity and use thereof
KR101092915B1 (ko) 성장인자―유래 펩타이드 및 이의 용도
US8691195B2 (en) Peptide having activity of transforming growth factor and production method therefor

Legal Events

Date Code Title Description
AS Assignment

Owner name: CAREGEN CO., LTD, KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHUNG, YONG JI;KIM, YOUNG DEUG;KIM, EUN MI;REEL/FRAME:021539/0176

Effective date: 20080825

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION